Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03803423|
Recruitment Status : Recruiting
First Posted : January 14, 2019
Last Update Posted : January 14, 2020
|Condition or disease||Intervention/treatment||Phase|
|End Stage Renal Disease End Stage Liver Disease||Other: The Donor App||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||1000 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||All participants will be invited to use the Donor App.|
|Masking:||None (Open Label)|
|Official Title:||Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors|
|Actual Study Start Date :||November 27, 2017|
|Estimated Primary Completion Date :||November 27, 2022|
|Estimated Study Completion Date :||November 27, 2022|
Experimental: The Donor App
Select physicians and research staff from about 15 transplant hospitals will be given access to distribute the application to patients who the above people feel could benefit from the application. After obtaining informed consent, an approved member of the study team will enter the participant's name, contact info, and organ needed into the Donor App's secure management portal to send an email or text message with a unique and protected invitation link to the participant. Using this link the participant will be allowed to use the Donor App indefinitely.
Other: The Donor App
The Donor app is a web-based application that helps transplant candidates tell the candidate's story via social media in the hopes of identifying an appropriate living donor. Sample stories created using the Donor App can be found at www.thedonorapp.com.
- Potential donors identified [ Time Frame: Up to 5 years ]Number of potential live donors that come forward to the transplant center on behalf of the participant.
- Live donor transplantation [ Time Frame: Up to 5 years ]Number of participants that receive a live donor transplant.
- App utilization as assessed by number of participants with story completion and posting in the donor app [ Time Frame: Up to 5 years ]The extent of a participants story completion and posting will be recorded internally by the Donor App. The number of participants that complete stories and post will be counted to assess app utilization.
- The Donor App Implementation [ Time Frame: Up to 5 years ]Success of the Donor App across multiple institutions will be tracked by the number of participants enrolled and invited to use the app at each institution.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03803423
|Contact: Andrew Cameron, MD PhDemail@example.com|
|United States, California|
|Scripps Green Hospital||Enrolling by invitation|
|San Diego, California, United States, 92037|
|United States, Connecticut|
|Yale University||Enrolling by invitation|
|New Haven, Connecticut, United States, 06520|
|United States, Illinois|
|Rush University Medical Center||Not yet recruiting|
|Chicago, Illinois, United States, 60612|
|Contact: Sherri Loeb, BSN|
|United States, Maine|
|Maine Medical Center||Enrolling by invitation|
|Portland, Maine, United States, 04102|
|United States, Maryland|
|The Johns Hopkins Hospital||Recruiting|
|Baltimore, Maryland, United States, 21218|
|Contact: Andrew Cameron, MD PhD 443-287-0134 firstname.lastname@example.org|
|Principal Investigator: Andrew Cameron, MD PhD|
|United States, Missouri|
|Washington University in St. Louis||Enrolling by invitation|
|Saint Louis, Missouri, United States, 63110|
|Principal Investigator:||Andrew Cameron, MD PhD||Johns Hopkins University|